German Society of
Oto-Rhino-Laryngology, Head and Neck Surgery

Press releases 2024

Press relations ENT Congress 2024
Overcoming boundaries together and shaping the future of ear, nose and throat medicine, head and neck surgery in an interdisciplinary, interprofessional and international framework - this was the motto of the traditional 95th Annual Meeting of the German Society for Ear, Nose and Throat Medicine, Head and Neck Surgery e.V. (DGHNO-KHC), which took place in Essen from May 8 to 11, 2024. The latest developments in the field of head and neck oncology, skull base, orbital and middle ear surgery as well as cochlear implant care were some of the current topics (link to press release).

Take a look at the detailed conference program (direct link) or at the press page of the ENT Congress (direct link)

Members of the press with questions are requested to contact the press office of the conference organization:
presse-hno@conventus.de. The press office will also be happy to put you in touch with contacts for interviews.

Press conference took place on


DGHNO-KHC 2024:
New data on sudden deafness therapy - current therapy standards put to the test
Bonn/Essen, 06.05.2024: Every year, several hundred thousand people worldwide suffer from sudden hearing loss. This sudden hearing loss without an identifiable cause is often treated with anti-inflammatory glucocorticoids, which are similar to the body's own cortisone. This therapy was systematically investigated for the first time in a nationwide study. The results are now the subject of heated debate among experts: Is the common therapy for sudden deafness effective at all? This is one of the exciting current topics at the 95th Annual Meeting of the German Society for Ear, Nose and Throat Medicine, Head and Neck Surgery (DGHNO-KHC) e. V. in Essen from May 8 to 11, 2024. more...


DGHNO-KHC 2024:
Neoadjuvant immunotherapy for the treatment of head and neck cancer - a paradigm shift?
Bonn/Essen, 03.05.2024: The latest scientific findings will be presented to a broad specialist audience at the 95th Annual Meeting of the German Society for Otorhinolaryngology, Head and Neck Surgery from May 8-11, 2024 in Essen, including important developments in the field of head and neck oncology. Neoadjuvant immunotherapy represents an important potential advance in the fight against cancer cells by stimulating the immune system at an early stage, even before conventional forms of treatment - primarily surgery - are used. By activating the body's own defenses at an early stage of the disease, this concept could help to improve the overall effectiveness of subsequent surgical or radiotherapeutic measures. more...

DGHNO-KHC 2024:
Examination and treatment of diseases of the eye socket - doctors focus on collaboration
Bonn/Essen, 03.05.2024: The interdisciplinary diagnosis and treatment of diseases of the eye socket, the so-called orbit, is one of the main topics of this year's German ENT Congress in Essen, which is being held under the motto "Crossing borders". With this theme, the German ENT Society is recognizing the great importance of the orbit for the field of ENT medicine as well as the high value of interdisciplinarity. The topic will be dealt with and presented by an ENT specialist and an ophthalmologist. more...


DGHNO-KHC 2024:
Innovative OTOF gene therapy for congenital deafness
Bonn/Essen, 02.05.2024: A special form of congenital deafness can be cured by gene therapy. Ellen Reisinger, Professor of Gene Therapy for Hearing Loss and Deafness at the University Hospital for ENT Medicine in Tübingen, has made a significant contribution to this success with her basic research. At the 95th Annual Meeting of the German Society for Otorhinolaryngology, Head and Neck Surgery (DGHNO-KHC) e. V. from May 8 to 11, 2024 in Essen, the expert will speak about this breakthrough in gene therapy for congenital hearing loss. more...

DGHNO-KHC 2024:
New diagnostic possibilities with increasing incidence of HPV-related cases of throat cancer
Bonn/Essen, 29.04.2024: More and more people in Germany are developing throat cancer, medically known as oropharyngeal carcinoma, as a result of an HPV infection. The human papillomavirus (HPV) is increasingly associated with the development of oropharyngeal cancer. To date, there is no reliable early detection of oropharyngeal cancer. At the 95th Annual Meeting of the German Society for Otorhinolaryngology, Head and Neck Surgery (DGHNO-KHC) e. V. from May 8 to 11, 2024 in Essen, the focus will be on the latest developments in the field of head and neck oncology. more...


DGHNO-KHC 2024:
Grenzen überschreiten - Interdisziplinär * International * Interaktiv
Bonn/Essen - 24.04.2024: The traditional and renowned annual meeting of the German Society for Otorhinolaryngology, Head and Neck Surgery - from May 8 to 11 - promises three days full of knowledge transfer, networking and inspiration. The conference is regarded as an outstanding event for exchanging the latest scientific findings in this field. Congress President and current President of the DGHNO-KHC, Prof. Dr. med. Stephan Lang, provides insights into the topics that will shape the annual conference. more...

Joint declaration by associations and organizations from the healthcare sector Democracy and pluralism as the foundation for a humane healthcare system 
Berlin - 18.03.2024: Democracy and pluralism are basic prerequisites for living in peace and freedom. They are fundamental to the well-being of our country and the foundation for living and working together in all areas of our society. The healthcare system in Germany in particular is based on these principles. Tolerance, humanity and diversity count here, because medicine knows no borders. Employees in our healthcare system come from all parts of the world. In accordance with our professional ethos, patients receive medical care regardless of their origin, gender, religion, social status or sexual orientation. more...

First S3 guideline published on the diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal cancer
Berlin - 13.03.2024: Better care for patients with head and neck tumors: The Oncology Guideline Program has published its first S3 guideline on the diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal cancer. The Oncology Guideline Program already has S3 guidelines for laryngeal and oral cavity cancer. Oropharyngeal carcinoma in particular is currently the most common malignant head and neck tumor in Germany and is particularly complex due to its various triggering factors. more...

ENT doctors and phoniatrists call for negotiations on ENT operations for children
Bonn/Neumünster/München/Göttingen - 28.02.2024: In a joint statement, the specialist societies and professional associations of ENT physicians as well as phoniatrists and pediatric audiologists renew their demand for cost-covering remuneration for ENT operations on children. According to the signatories, politicians and health insurance companies continue to refuse serious negotiations on the valuation of adenotomies (adenoid removal/tympanostomy tube insertion) and tonsillotomies (partial removal of the palatine tonsil). more...

DFG Junior Researcher Academy for ENT Medicine promotes interdisciplinary exchange between young scientists
Bonn/Göttingen – Januar 2024: The academy week of the first DFG Young Investigators Academy for ENT Medicine took place in Göttingen last December. Prof. Guntinas-Lichius from Jena, Chairman of the Steering Committee of the German ENT Study Center (DSZ-HNO), is in charge of the academy, which is funded by the German Research Foundation (DFG). The week-long event was supervised by PD Dr. Joanna Napp and Corinna Jansen from the UMG study center in Göttingen. more...

> Download picture: Participating DFG Young Investigators Academy 12-23

Hearing loss: therapy with high-dose medication offers no advantages over standard treatment
Halle/S., Bonn - Januar 2024: In the case of sudden hearing loss, high-dose therapy with common medications does not help any more than standard therapy, but is associated with more side effects. This was shown by a nationwide study led by the University Medical Center Halle. The team conducted a systematic clinical study with over 300 patients. The results published in the specialist journal "NEJM Evidence" also raise the question of whether the current standard therapy itself is effective at all. According to conservative estimates, several hundred thousand people worldwide suffer sudden hearing loss every year.. more...